Cancer Knowledge Hub — Expert-reviewed insights

Cancer insights that inform better decisions

Step-by-step guides, research summaries, and treatment overviews — reviewed by oncology navigators and written clearly for patients, families, and caregivers.

From newly diagnosed to relapsed and refractory — we publish what patients actually need to understand their options.

Browse all insights

Talk to a navigator WhatsApp

Reviewed by oncology navigators Updated regularly 50+ countries reached Clinically grounded

What are you looking for today?

CAR-T therapy Clinical trial eligibility Biomarkers Second opinion Proton therapy

What you'll find here

Insights built for complex decisions

CancerFax Insights exists because cancer patients face decisions that are genuinely hard — not because of lack of will, but because the information landscape is fragmented, fast-moving, and often written for clinicians, not families.

Every insight published here is reviewed by our oncology navigation team before it goes live. We focus on the questions patients actually ask us: What is this treatment? Who qualifies? What should I prepare? What should I ask my doctor?

Use the search and filters below to find what's most relevant to your situation.

Featured insight

This week's editor's pick

Treatment guide

A practical walk-through for patients and families evaluating CAR-T, TIL, and other advanced cell therapies.

Step-by-step patient guide

CAR-T therapy: what families need to ask their oncologist

Before agreeing to CAR-T therapy, families need to understand eligibility criteria, the manufacturing timeline, expected side effects, and what happens if the therapy fails. This guide walks through every question your team should be able to answer.

Reviewed by oncology team8 min read

Read insight

What we cover

Six insight categories

Browse by the topic most relevant to where you are in your cancer journey right now.

Treatment guides

Compare options, evaluate trade-offs, understand what questions to ask before agreeing to a specific protocol.

CAR-TImmunotherapyGene therapy

Browse treatment insights 02

Clinical trial insights

How trial matching works, eligibility logic explained, document checklists, and what to expect during screening.

EligibilityMutation matchPhase II

Read trial insights 03

Precision oncology

NGS testing, biomarker-based treatment matching, liquid biopsy, tumour mutation burden, and targeted therapy guides.

NGSLiquid biopsyBiomarkers

Open precision insights 04

International care

Cross-border treatment pathways, China and India access, visa planning, cost estimates, and logistics walk-throughs.

China accessIndiaCost planning

Explore international care 05

Caregiver & family

Practical guides for families, partners, and adult children walking alongside someone in cancer treatment.

CaregivingRecordsCommunication

Find caregiver guides 06

Second opinions

How to prepare records, frame clinical questions, compare opinions, and navigate specialist review across borders.

Records prepCross-borderQuestions

Plan a second opinion

Cancer insights library

Browse the full library

Search, filter, and explore all published insights — by cancer type, treatment category, clinical trial readiness, or stage of your journey.

Search across cancer types, treatments, mutations, drugs, and trials

1 of 1 insight

Neuro-Oncology

Glioblastoma (GBM) Treatment: Options and Advanced Approaches

Glioblastoma (GBM, WHO Grade 4 glioma) is the most aggressive primary brain tumour. Standard treatment — maximal safe resection followed by temozolomide + radiotherapy (Stupp protocol) — achieves a median OS of 14–16 months. Advanced approaches including BNCT, tumour treating fields (TTFields), immunotherapy clinical trials, and oncolytic virotherapy are expanding options for newly diagnosed and recurrent GBM patients, particularly through clinical trial access in Asia.

11 minJun 1Reviewed

By stage of journey

Find insights for your situation

Where are you in your cancer journey? Find insights matched to your current situation.

Newly diagnosed

Understand your diagnosis, staging, reports, and first-line options before making major decisions.

Read newly-diagnosed insights

Treatment not working

Explore second opinions, molecular testing, clinical trials, and international advanced options.

Explore next-step insights

Looking for clinical trials

Learn how trial matching, eligibility review, and mutation-based screening actually work.

View clinical trial insights

Comparing countries

Understand how destination, treatment availability, cost, and expertise shape cross-border decisions.

Compare destinations

Deep dives

Advanced insight groups

Curated reading lists for patients going deep into a specific treatment category or clinical question.

Cell & gene therapy

Living medicines, re-engineered

Precision oncology

Treatment matched to biology

Advanced radiation & local therapies

Targeted at the tumour, not the body

Treatment categories

Browse by treatment type

Explore insights and guides organised by the treatment modality most relevant to your case.

CAR T-cell therapy TIL therapy Cancer immunotherapy Targeted therapy Proton therapy BNCT Gene therapy CAR-NK therapy Oncolytic virus therapy Radioligand therapy HIFU TACE TARE HIPEC Bone marrow transplant Robotic cancer surgery

By cancer type

Insights by cancer type

Find content specific to your diagnosis — from treatment overviews to clinical trial access and second opinion guidance.

Lung cancer Breast cancer Liver cancer Gastric cancer Colorectal cancer Pancreatic cancer Prostate cancer Ovarian cancer Cervical cancer Leukemia Lymphoma Multiple myeloma Neuroblastoma Sarcoma Brain tumours

Clinical trial access

Access to trials unavailable at home

CancerFax connects patients with clinical trials in China, India, and leading global centres — including phase I and II trials closed to international enrolment through standard channels.

Browse clinical trials Talk to a navigator

500+

active clinical trials across China, India, and leading global centres

40+

cancer types with current advanced therapy access pathways

12+

years of patient navigation experience in cross-border oncology

Curated reading

Why we publish independently

CancerFax Insights is editorially independent of the hospitals, pharmaceutical companies, and treatment centres we work with. Our navigation team writes what patients need to hear — not what any institution wants them to read.

That means we tell patients when a treatment is likely out of reach, when a clinical trial has closed, and when the evidence for a new therapy is still thin. We believe informed patients make better decisions and have better outcomes — even when the honest answer is harder to hear.

— CancerFax oncology navigation team

Questions

About CancerFax Insights

How our content is produced, reviewed, and how to use it effectively.

What kind of insights does CancerFax publish?

CancerFax publishes expert-reviewed, patient-facing content covering advanced cancer treatments, clinical trials, precision oncology, international care pathways, and caregiver guidance. Every insight is reviewed by our oncology navigation team before publication.

Are these insights written for patients or medical professionals?

Our insights are written primarily for patients, families, and caregivers — but are clinically grounded enough to be a useful reference for healthcare professionals. We aim for clarity without oversimplification.

How often is content updated?

Insights are reviewed and updated regularly, especially when new clinical data or trial results change the standard of care. The last review date is shown on each article.

Can I use these insights to make treatment decisions?

Our insights are educational — they help you understand options, ask better questions, and prepare for medical consultations. They do not replace the advice of your treating oncologist. If you need structured guidance for your specific case, our navigation team can help.

How do I find insights relevant to my cancer type?

Use the search bar above to filter by cancer type, treatment name, mutation, or stage. You can also browse by topic category using the filter pills, or use the cancer type tags in the sidebar.

Ready to go further?

Get personalised guidance for your case

Our oncology navigators review your medical records, explain your options in plain language, and help you access the right specialists, trials, and treatment centres — wherever you are in the world.

Talk to a navigator Browse clinical trials

Every navigation request is reviewed by a qualified oncology professional. We do not recommend treatments without reviewing your medical records.

Cancer insights that inform better decisions

Insights built for complex decisions

This week's editor's pick

CAR-T therapy: what families need to ask their oncologist

Six insight categories

Treatment guides

Clinical trial insights

Precision oncology

International care

Caregiver & family

Second opinions

Browse the full library

Glioblastoma (GBM) Treatment: Options and Advanced Approaches

Find insights for your situation

Newly diagnosed

Treatment not working

Looking for clinical trials

Comparing countries

Advanced insight groups

Living medicines, re-engineered

Treatment matched to biology

Targeted at the tumour, not the body

Browse by treatment type

Insights by cancer type

Access to trials unavailable at home

Editor's picks

CAR-T therapy: what families need to ask their oncologist

International second opinion: a step-by-step preparation checklist

Understanding NGS reports: a patient-friendly guide

When standard treatment stops working: what to do next

China clinical trials: eligibility and how to apply

Liquid biopsy explained: how it guides treatment decisions

Why we publish independently

Get new cancer insights, written carefully

About CancerFax Insights

Get personalised guidance for your case